Viatris Inc.
$32.48B- Market cap
- $19.39B
- Debt
- +$14.41B
- Cash
- −$1.32B
Capital structure 57% equity / 43% debt · EV / Revenue 2.27x · EV / EBITDA 1393.83x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $19.39B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2026 ·
Decision snapshot: VTRS stock price near parity vs SJM $16.88 current versus $18.53 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SJM's multiple
Implied fair value · at VTRS's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: VTRS FY 2025 (ended Dec 31, 2025) · SJM FY 2026 (ended Apr 30, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 57% equity / 43% debt · EV / Revenue 2.27x · EV / EBITDA 1393.83x
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 67% equity / 33% debt
VTRS carries the larger enterprise value at $32.48B against $20.16B; SJM trades on the lower EV / Revenue multiple (2.23x vs 2.27x); SJM on the lower EV / EBITDA (40.76x vs 1393.83x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
VIATRIS INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
The J. M. Smucker Company · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.98x
1.21x
Net debt / EBITDA
Leverage against operating earnings
561.72x
—
Cash and equivalents
Liquid reserves on the balance sheet
$1.32B
—
Total debt
Interest-bearing obligations outstanding
$14.41B
$6.69B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
PFIZER INC
VTRS vs PFE
Organon & Co.
VTRS vs OGN
BRISTOL MYERS SQUIBB CO
VTRS vs BMY
AbbVie Inc.
VTRS vs ABBV
Merck & Co., Inc.
VTRS vs MRK
COCA COLA CO
VTRS vs KO
PEPSICO INC
VTRS vs PEP
GENERAL MILLS INC
VTRS vs GIS
COLGATE PALMOLIVE CO
VTRS vs CL
Lamb Weston Holdings, Inc.
VTRS vs LW
HORMEL FOODS CORP /DE/
VTRS vs HRL
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.